TechMARK movers: Elan up on Johnson & Johnson deal - Silobreaker

Silobreaker Logotype

NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Sunday, March 21, 2010 2:21 AM

Published Jul 02 2009 by ShareCast

TechMARK movers: Elan up on Johnson & Johnson deal

LONDON (SHARECAST) - Shares in Elan rallied on news that Johnson & Johnson will acquire substantially all of the assets and rights of the Irish drug firm related to its Alzheimer's Immunotherapy Program. Johnson & Johnson, through its affiliate, will invest $1bn in Elan in exchange for...

READ FULL ARTICLE

Share this

What others report on the same story

Elan Shares Rise on J&J Investment

Elan(ELN Quote) shares rose Thursday after health care giant Johnson & Johnson(JNJ Quote) said it was spending $1 billion to acquire a minority stake in the Irish ... - [Jul 02 2009 - TheStreet.com]

Elan Shares Rise on J&J Investment - [Jul 02 2009 - TheStreet.com]

TechMARK movers: Elan up on Johnson & Johns... - [Jul 02 2009 - ShareCast]

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

US Securities and Exchange Commission

US Securities and Exchange Commission

Johnson & Johnson CEO received 11 percent raise in 2009

Patti Sapone/The Star-LedgerBill Weldon, who has been J&Js CEO and chairman since 2002, received 2009 compensation valued at $25.6 million, based on figures in the company proxy statement filed Wednesday with the Securities and Exchange Commission.The ... [Published Mar 19 2010 by Star Ledger]

Entities: Johnson & Johnson, Stock Option, US Securities and Exchange Commission, Fiscal Year

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

New York Stock Exchange

Johnson and Johnson (JNJ) Hits 52-Week High - Zibb.com

(Fresh Brewed Media via COMTEX) --Company: Johnson & Johnson (JNJ)Johnson and Johnson (NYSE: JNJ) hit a new 52-Week high of $65.49 so far today. Currently the stock is down $0.14 (-0.22%) to $64.92 on 11,363,290 shares traded. Today's high is up $15.43 ... [Published Mar 19 2010 by Zibb]

Entities: Johnson & Johnson, Credit Spreads, New York Stock Exchange

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Cantor Fitzgerald LP

Sanofi-Aventis (SNY) Pushing to Session Highs Following Cantor Fitzgerald Upgrade

Although the stock is still down about 0.8% for the sessions, shares of Sanofi Aventis (NYSE: SNY) have now pushed to fresh intraday highs. The stock began moving sharply higher just after noon following an intraday upgrade from an analyst at Cantor Fitzgerald. ... [Published Mar 19 2010 by Street Insider]

Entities: Sanofi-Aventis SA, Cantor Fitzgerald LP, Vaccine, New York Stock Exchange, Health Care

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

Johnson & Johnson

Trial results of J&J's bapineuzumab might not come until 2012

Results of a large trial of Alzheimer's disease drug bapineuzumab might not be available until 2012 because maker Johnson & J - More - ... [Published Mar 19 2010 by SmartBrief]

Entities: Johnson & Johnson, Alzheimer's Disease

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

ProStrakan posts strong revenue rise

Drugs firm cuts operating losses by 50 pcProstrakan has reported a strong revenue rise and reduced its operating losses by more than 50 per cent.The Galashiels pharmaceutical company said total revenues were up by 41 per cent to $79million, largely through ... [Published Mar 19 2010 by Business 7]

Entities: ProStrakan Group Plc, Galashiels (United Kingdom), Testosterone

First Reported Mar 19 2010 - Updated Mar 19 2010 - 1 Documents

J&J, Sanofi, Pfizer Speed Testing for New Tuberculosis Drug

File photoThe U.S. Food and Drug Administration is changing rules for testing tuberculosis drugs to enable Johnson & Johnson, Sanofi-Aventis SA and Pfizer Inc. to speed up approval of new combination treatments by decades, Bloomberg reports.At least 10 ... [Published Mar 19 2010 by Star Ledger]

Entities: Tuberculosis, Johnson & Johnson, Pfizer Inc

First Reported 15 hours ago - Updated 15 hours ago - 1 Documents

Sanofi-Aventis SA

Dubai Health Authority, Sanofi-aventis ink diabetes campaign

The Dubai Health Authority and Sanofi-aventis pharmaceuticals Gulf have signed a contract for an extensive three-year diabetes awareness campaign in the UAE. The campaign will focus on education of patients and physicians through targeted support programs ... [Published 15 hours ago by AME Info]

Entities: Diabetes, Sanofi-Aventis SA, Dubai

Products & Services
Silobreaker.com
Enterprise Online Service
Enterprise Software Suite
Widgets & API

How To Use
Silobreaker
RSS
API
Widgets

Advertise With Us
Advertise

Follow Us
Press Room
Blog
YouTube
Twitter

About Us
About Silobreaker
Background and History
Why Silobreaker?
Value Proposition
Technology
Team
Contact Us

Legal
Terms of Use
Privacy Policy

Freebase CC-BY

Some image thumbnails are sourced from Freebase, licensed under CC-BY
Copyright (C) 2009 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.